meiragtx
The role focuses on driving the execution of in‑vivo gene therapy potency assays and safety studies, supporting both early discovery and ongoing clinical projects. The scientist will develop and implement new technologies, draft SOPs, and collaborate with R&D, compliance, and quality teams in a matrix environment.
Headquarters
London, England, United Kingdom
Company Size
51-200 employees
Founded
2015
MeiraGTx is a clinical-stage genetic medicine company with a global footprint focused on developing next‑generation, potentially curative treatments for patients living with serious diseases. The company advances gene‑based therapies through discovery and clinical development to address unmet medical needs. MeiraGTx emphasizes translational science and scalable manufacturing to deliver durable, patient‑focused genetic medicines worldwide.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for meiragtx.
meiragtx didn’t post a salary, so this is our estimate from similar listings.
34% below the average for this role
Scientist II, Gene Therapy
Insmed Incorporated
Scientist – In Vivo CAR-T Therapy
Legend Biotech
Associate Scientist
Syngene International Limited
Postdoctoral Scientist – Gene Therapy Biodistribution & Molecular Biology (CNS)
Eli Lilly and Company
Senior Research Assistant
Baylor College of Medicine
Senior Research Associate, In Vivo Discovery
Pivotal